Table 6.

Multivariate cox-proportional hazard analysis of 3-year events, based on statins prescription at discharge (N = 12,200).

Events	With statins (N = 11,415)	Without statins (N = 785)	Hazard ratio* (95% CI)	P value
	No. of patients with events (rate per 100 patient-year†)
Cardiac death	549 (1.8)	96 (5.1)	0.74 (0.59–0.93)	.011
All-cause death	889 (2.9)	147 (7.7)	0.74 (0.61–0.89)	.001
MI	365 (1.2)	32 (1.7)	0.97 (0.66–1.43)	.880
Revascularization	973 (3.4)	73 (4.1)	0.83 (0.65–1.06)	.128
Heart failure‡	404 (1.3)	56 (3.1)	0.83 (0.61–1.12)	.216
MACE	1809 (6.4)	199 (11.7)	0.81 (0.70–0.95)	.008
Stroke	230 (0.8)	23 (1.2)	0.78 (0.50–1.23)	.287
MACCE	1985 (7.1)	219 (13.1)	0.79 (0.68–0.92)	.002
NCD	51 (2.7)	147 (7.7)	0.73 (0.53–1.002)	.052
MACE with NCD	2103 (7.4)	238 (14.0)	0.81 (0.70–0.93)	.003

Abbreviations: CI = confidence interval, MACCE = major adverse cardiocerebral event, MACE = major adverse cardiac event, MI = myocardial infarction, NCD = noncardiac death.

^*Adjusted for age, sex, body mass index, hypertension, diabetes mellitus, prior angina, prior MI, prior heart failure, current smoker status, Killip class, estimated glomerular filtration rate, left ventricular ejection fraction, type of myocardial infarction, coronary reperfusion, and medications at discharge (aspirin, P2Y12 inhibitors, beta-blockers, and inhibitors of the renin-angiotensin system)

^†Unadjusted event rate.

^‡Re-hospitalization due to heart failure.